Intraoperative cell salvage in obstetrics

Bernstein HH Rosenblatt MA Gettes M Lockwood C 1997 The ability of the Haemonetics 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid Anesthesia & Analgesia 85 831–833

Camann W 1999 Cell salvage during caesarean delivery: is it safe and valuable? Maybe, maybe not! (Editorial) International Journal of Obstetric Anaesthesia 8 75–76

Carless PA Henry DA Moxey AJ O’Connell D Brown T Fergusson DA 2010 Cell salvage for minimising perioperative allogeneic blood transfusion Cochrane Database of Systematic Reviews Issue 3. Available from: www.thecochranelibrary.com/SpringboardWebApp/us erfiles/ccoch/file/CD001888.pdf [Accessed April 2011]

Catling SJ Freites O Krishnan S Gibbs R 2002 Clinical experience with cell salvage in obstetrics: four cases from one UK centre International Journal of Obstetric Anesthesia 11 128–134

Catling S Joels L 2005 Cell salvage in obstetrics – the time has come! British Journal of Obstetrics & Gynaecology 112 (2) 131–132

Catling SJ Williams S Fielding AM 1999 Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section International Journal of Obstetric Anesthesia 8 79–84

Chief Medical Officer’s National Blood Transfusion Committee 2009 A plan for NHS blood and transplant and hospitals to address red cell shortages London, DH http://hospital.blood.co.uk/media/2312/d09363f3-2158-425a-a02f-7759573b1daa.pdf [Accessed April 2011]

Clarke SL Hankins DV Dudley DA Dildy GA Porter TF 1995 Amniotic fluid embolism; analysis of the national registry American Journal of Obstetrics & Gynecology 172 1158–1169

Confidential Enquiry into Maternal and Child (CEMACH) 2000-2002 Why mothers die: Report on confidential enquiries into maternal deaths in the United Kingdom Chapter 4 91-92. London, CEMACH

Department of Health 1998 Health Service Circular Better Blood Transfusion (HSC 1998/224) London, DH www.dh.gov.uk/prod_consum_dh/groups/dh_digitalas sets/@dh/@en/documents/digitalasset/dh_4011919.pdf [Accessed April 2011]

Department of Health 2002 Health Service Circular Better Blood Transfusion: Appropriate use of blood (HSC 2002/009) London, DH www.dh.gov.uk/prod_consum_dh/groups/dh_digitalas sets/@dh/@en/documents/digitalasset/dh_4012293.pdf [Accessed April 2011]

Department of Health 2007 Health Service Circular Better Blood Transfusion: Safe and appropriate use of blood (HSC 2007/001) www.dh.gov.uk/prod_consum_dh/groups/dh_digitalas sets/documents/digitalasset/dh_080803.pdf [Accessed April 2011]

Farrar SC Gherman RB 2001 Serum tryptase analysis in a woman with amniotic fluid embolism. A case report Journal of Reproductive Medicine 6 (10) 926–928

Fineschi V Gambassi R Gherardi M Turillazzi E 1998 The diagnosis of amniotic fluid embolism: an immunohistochemical study for the quantification of pulmonary mast cell tryptase International Journal of Legal Medicine 111 (5) 238–243

Fong J Gurewitsch ED Kumip L Klein R 1999 Clearance of fetal products and subsequent immunoreactivity of blood salvaged at caesarean delivery Obtstetrics & Gynecology 93 968–972

Hébert PC Wells G Blajchman MA et al 1999 A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care New England Journal of Medicine 340 (6) 409–417

Hussain S Clyburn P 2010 Cell salvage – induced hypotension and London buses. Editorial Anaesthesia 65 661–663

Iwama H 2001 Bradykinin-associated reactions in white cell reduction filter Journal of Critical Care 16 74–81

Jackson SH Lonser RE 1993 Safety and effectiveness of intracaesarean blood salvage Transfusion 33 181

National Institute for Health & Clinical Excellence 2005 Intra-operative blood cell salvage in obstetrics: Guidance Available from: http://guidance.nice.org.uk/IPG144/Guidance/pdf/English [Accessed June 2011]

Obstetric Anaesthetists’ Association/Association of Anaesthetists of Great Britain and Ireland 2005 Guidelines for obstetric anaesthetic services Revised edition London, AAGBI p25

Potter PS Waters JH Burger GA Mraovic B 1999 Application of cell salvage during caesarean section Anesthesiology 90 619–621

Rebarber A Lonser R Jackson S Copel JA Sipes S 1998 The safety of intraoperative autologous blood collection and autotransfusion during caesarean section American Journal of Obstetric Gynecology 179 715–720

Rainaldi MP Tazzari PL Scagliarini G Borghi B Conte R 1998 Blood salvage during caesarean section British Journal of Anaesthesiology 80 196–198

Serious Hazards of Transfusion Scheme 1997-2009 SHOT Reports Manchester, SHOT www.shotuk.org/home [Accessed April 2011]

Sullivan I Faulds J Ralph C 2008 Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section British Journal of Anaesthesia 10 225–229

Teig M Clarke V Catling S 2007 Survey of cell salvage use in obstetrics in the UK International Journal of Obstetric Anesthesia 16 (S) 30

Thornhill ML O’Leary AJ Lusson SA Rutherford C Johnson MD 1991 An in vitro assessment of amniotic fluid removal from human blood through cell saver processing Anesthesiology 75A 830

UK Cell Salvage Action Group 2007 Policy for the provision of intraoperative cell salvage Available from: www.transfusionguidelines.org.uk/docs/misc/bbt-03_icsag-policy-v11.doc [Accessed April 2011]

Waters JH 2009 Cell salvage and bowel contamination Transfusion Alternatives in Transfusion Medicine (abstract) 11 (1) 16

Waters JH Biscotti MD Potter PS Phillipson E 2000 Amniotic fluid removal during cell salvaged in the caesarean section patient Anesthesiology 92 1531–1536

Waterstone M Bewely S 2001 Incidence and predictors of severe obstetric morbidity: a case control study British Medical Journal 322 1089–1093

Wells AW Mounter PJ Chapman CE et al 2002 Where does blood go? British Medical Journal 325 803–804

Weiskopf RB 2000 Erythrocyte salvage during caesarean section. Editorial Anesthesiology 92 1519–1522

Zoon KC Jacobsen ED Woodcock J 1999 Hypotension and bedside leukocyte reduction filters: letter to industry/healthcare providers Rockville, MD, US Food and Drug Administration for Biologics Evaluation and Research